Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q1 2023 · 10-Q
Revenue$311.32K$311.32Kno prior Q1 2022 on file Net Income-$1.21M-$1.21MN/M vs Q1 2022 EPS Diluted-$1.62-$1.62N/M vs Q1 2022 Operating Income-$1,218,372N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Margins · derivedOperating margin-391.4%
Net margin-388.1%
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end